ASPG and extranodal nasal NK/T cell lymphoma: Two patients with extranodal NK/T cell lymphoma received methotrexate (3 g, day 1), heterocyclic phosphamide (3 g, day 2; 2 g, day 3–4), dexamethasone (40 mg, days 2–4), etoposide (100 mg, days 2–4), and asparaginase (10,000 U; days 8, 10, and 13) (SIMLE regimen).